LAUNCH Program
@u2c-tl1-launch.bsky.social
The U2C/TL1 LAUNCH Program is a multi-institutional training program for pre- and post-docs to creatively and collaboratively innovate in KUH disciplines.
check us out: launch.ucsf.edu
check us out: launch.ucsf.edu
Pinned
Apply now for research training support! Applicants must be researchers in nephrology, urology, or hematology from UCSF, UC Berkeley, UC Davis, or Stanford University to be considered. @stanfordmedicine.bsky.social @ucsfhealth.bsky.social @ucdavis.bsky.social @ucberkeleyofficial.bsky.social
Recent publication by LAUNCH affiliate @arahmadi.bsky.social and alumnus Heiko Yang: Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Congrats Armin and Heiko! pubmed.ncbi.nlm.nih.gov/40333014/ @broshanr.bsky.social
Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys - PubMed
Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP.
pubmed.ncbi.nlm.nih.gov
June 4, 2025 at 5:06 PM
Recent publication by LAUNCH affiliate @arahmadi.bsky.social and alumnus Heiko Yang: Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Congrats Armin and Heiko! pubmed.ncbi.nlm.nih.gov/40333014/ @broshanr.bsky.social
Reposted by LAUNCH Program
Apply now for research training support! Applicants must be researchers in nephrology, urology, or hematology from UCSF, UC Berkeley, UC Davis, or Stanford University to be considered. @stanfordmedicine.bsky.social @ucsfhealth.bsky.social @ucdavis.bsky.social @ucberkeleyofficial.bsky.social
January 21, 2025 at 7:17 PM
Apply now for research training support! Applicants must be researchers in nephrology, urology, or hematology from UCSF, UC Berkeley, UC Davis, or Stanford University to be considered. @stanfordmedicine.bsky.social @ucsfhealth.bsky.social @ucdavis.bsky.social @ucberkeleyofficial.bsky.social
Apply now for research training support! Applicants must be researchers in nephrology, urology, or hematology from UCSF, UC Berkeley, UC Davis, or Stanford University to be considered. @stanfordmedicine.bsky.social @ucsfhealth.bsky.social @ucdavis.bsky.social @ucberkeleyofficial.bsky.social
January 21, 2025 at 7:17 PM
Apply now for research training support! Applicants must be researchers in nephrology, urology, or hematology from UCSF, UC Berkeley, UC Davis, or Stanford University to be considered. @stanfordmedicine.bsky.social @ucsfhealth.bsky.social @ucdavis.bsky.social @ucberkeleyofficial.bsky.social
Another cool publication from LAUNCH alumnus Robin Lo-- ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling insight.jci.org/articles/vie... #stanfordnephrology @bhallaresearch.bsky.social Congrats Robin!
JCI Insight -
ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling
insight.jci.org
December 12, 2024 at 11:50 PM
Another cool publication from LAUNCH alumnus Robin Lo-- ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling insight.jci.org/articles/vie... #stanfordnephrology @bhallaresearch.bsky.social Congrats Robin!
Recent pub by @U2C_TL1_LAUNCH alum Heiko Yang @ucsfnephrology.bsky.social #ucsfurology The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria: pubmed.ncbi.nlm.nih.gov/39589516/. Congrats Heiko!
The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria - PubMed
The Maillard reaction is a non-enzymatic reaction between an amino acid and carbohydrate. We hypothesized that continuous washing of cystine stones with glucose could theoretically prevent growth of a...
pubmed.ncbi.nlm.nih.gov
December 7, 2024 at 12:09 AM
Recent pub by @U2C_TL1_LAUNCH alum Heiko Yang @ucsfnephrology.bsky.social #ucsfurology The potential role of Sodium/Glucose Cotransporter 2 inhibitors in the treatment of cystinuria: pubmed.ncbi.nlm.nih.gov/39589516/. Congrats Heiko!